U.S. Point-of-Care Retail Diagnostics Markets

Ease-of-use and Forceful Marketing Expected to Drive OTC Tests and Monitors Markets

“Simple designs that aid convenience, accessibility, facility of interpretation, and instant results are major factors driving demand for OTC pregnancy and ovulation

tests as well as cholesterol tests and monitors.”

Discovery and Diagnostics Analyst Team

Frost & Sullivan

• The ovulation market will continue to focus on technological innovations to increase brand name recognition and market share

• Marketing strategies will target key consumers of ovulation products to maximize benefit of limited marketing dollars

• Pregnancy test manufactures will continue claim driven marketing strategies to differentiate products that are largely perceived as commodities by consumers

• At-home cholesterol tests and monitors will experience substantial sales increases as the public accepts the health risks associated with elevated cholesterol

Industry Trends

Frost & Sullivan provides:

• Detailed insights into recent developments

• Analysis of market, technology, and end-user trends

• Drivers, restraints, challenges, and strategic recommendations

• Analyst insights on technological innovations

• Market sizing and competitive structure analysis

• Market forecasts and opportunity analysis

Key Features

• Coverage of the Clinical Diagnostic Industry

• Proven methodology encompassing extensive primary and secondary data and research

• Focused information and strategies that cover business and technology issues

• Credible data and analysis highlighting industry dynamics

• Winning strategies to help you create precise business plans

What We Offer

Current Market Participants• Find out how you compare to the competition• Assess current and future drivers and restraints• Determine and exploit new market share opportunities

New Entrants • Analyze challenges associated with the industry• Calculate time scales for strategy implementation• Position yourself to capitalize on the market’s unmet needs

Investment Community• Analyze long-term strategies of clinical diagnostic companies• Determine which participants will outperform the competition• Assess attractiveness of investing in the clinical diagnostic industry

Who Will Benefit?

• Market & technology trends and developments

• Forecast model integrating a bottom-up approach with demand side penetration analysis

• Business models and alliance opportunities

• Incorporation of end user feedback in analysis

• Overview of competitive landscape and key success factors

• Analysis of firms likely to excel in the market

• Frost & Sullivan’s Market Engineering Analysis

What’s Included

Abbott Laboratories/ Ross Products Div.AccuTech LLCAcon Laboratories, Inc.AmeriTek, Inc.Armkel LLC(Church & Dwight Co.)Chmeatics, Inc.Choletech Corp.Cortez Diagnostics, Inc.Genzyme DiagnosticsGermaine Laboratories, Inc.Home Access Health Corp.Inverness Medical Ltd.

Lifestream Technologies, Inc.Perrigo Co.Pfizer, Inc.Pheromone Sciences Corp.Phamatech, Inc.Polymer Technology Systems, Inc.Princeton BioMeditech Corp.Quidel Corp.SA Scientific, Inc.Scantibodies Laboratory, Inc.Syntron, Inc. Zetek, Inc.

Key Market Participants

• Call toll free 877 GO FROST

(877.463.7876)

• Fax toll free 888.690.3329

• Email myfrost@frost.com

• Visit www.frost.com

For More Information